Zymeworks Interest Income from 2010 to 2026

ZYME Stock

USD 23.12 0.32 1.37%

Zymeworks Common's Interest Income is increasing over the years with slightly volatile fluctuation. Overall, Interest Income is expected to go to about 24.1 M this year. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-03-31

Previous Quarter

3.4 M

Current Value

3.5 M

Quarterly Volatility

1.9 M

Covid

Interest Hikes

Check Zymeworks Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zymeworks Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.1 M, Interest Expense of 5.8 M or Selling General Administrative of 43.8 M, as well as many indicators such as Price To Sales Ratio of 15.9, Dividend Yield of 0.0 or PTB Ratio of 6.96. Zymeworks financial statements analysis is a perfect complement when working with Zymeworks Common Valuation or Volatility modules.

Build AI portfolio with Zymeworks Stock

Check out the analysis of Zymeworks Common Correlation against competitors.

Analyzing Zymeworks Common's Interest Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Interest Income has evolved provides context for assessing Zymeworks Common's current valuation and future prospects.

Latest Zymeworks Common's Interest Income Growth Pattern

Below is the plot of the Interest Income of Zymeworks Common Stock over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Zymeworks Common's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zymeworks Common's overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Zymeworks Interest Income Regression Statistics

	Arithmetic Mean	6,653,548
	Geometric Mean	2,617,072
	Coefficient Of Variation	132.24
	Mean Deviation	7,063,849
	Median	2,505,414
	Standard Deviation	8,798,523
	Sample Variance	77.4T
	Range	23.8M
	R-Value	0.82
	Mean Square Error	27.2T
	R-Squared	0.67
	Significance	0.000058
	Slope	1,426,695
	Total Sum of Squares	1238.6T

Zymeworks Interest Income History

	2026	24.1 M
	2025	22.9 M
	2024	19.9 M
	2023	19.7 M
	2022	3.6 M
	2021	2.5 M
	2020	5.7 M

Other Fundumenentals of Zymeworks Common Stock

Net Interest Income

Zymeworks Common Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Long Term Debt	Good Will	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.9	0.9	-0.7	-0.88	0.93	0.63	0.93	-0.19	0.98	0.92	0.62	0.89	0.83	0.51	0.84	0.9	0.72	0.55	-0.84	-0.22	-0.84	0.98	0.95	0.89
Total Stockholder Equity	0.9		0.83	-0.69	-0.82	0.87	0.62	0.8	-0.22	0.88	0.91	0.45	0.82	0.78	0.46	0.65	0.87	0.55	0.5	-0.66	-0.19	-0.66	0.92	0.86	0.88
Net Tangible Assets	0.9	0.83		-0.45	-0.93	0.78	0.87	0.81	-0.27	0.86	0.96	0.33	0.98	0.95	0.42	0.81	0.95	0.59	0.81	-0.8	-0.56	-0.8	0.92	0.85	0.93
Net Debt	-0.7	-0.69	-0.45		0.41	-0.83	-0.13	-0.62	0.2	-0.79	-0.54	-0.62	-0.41	-0.35	-0.28	-0.32	-0.51	-0.45	0.15	0.47	-0.17	0.47	-0.71	-0.82	-0.43
Retained Earnings	-0.88	-0.82	-0.93	0.41		-0.76	-0.84	-0.86	0.18	-0.81	-0.9	-0.34	-0.97	-0.92	-0.62	-0.72	-0.98	-0.68	-0.75	0.77	0.45	0.77	-0.89	-0.79	-0.96
Accounts Payable	0.93	0.87	0.78	-0.83	-0.76		0.47	0.91	-0.08	0.96	0.85	0.7	0.77	0.71	0.48	0.7	0.83	0.69	0.32	-0.72	-0.16	-0.72	0.93	0.97	0.75
Net Receivables	0.63	0.62	0.87	-0.13	-0.84	0.47		0.61	-0.14	0.55	0.77	-0.06	0.88	0.91	0.36	0.52	0.84	0.39	0.86	-0.54	-0.75	-0.54	0.68	0.54	0.85
Total Liab	0.93	0.8	0.81	-0.62	-0.86	0.91	0.61		0.06	0.9	0.81	0.66	0.84	0.77	0.66	0.76	0.87	0.82	0.47	-0.78	-0.23	-0.78	0.89	0.87	0.82
Short Long Term Debt	-0.19	-0.22	-0.27	0.2	0.18	-0.08	-0.14	0.06		-0.23	-0.2	0.23	-0.21	-0.14	-0.11	-0.18	-0.21	0.17	-0.18	0.28	0.08	0.28	-0.22	-0.22	-0.2
Total Current Assets	0.98	0.88	0.86	-0.79	-0.81	0.96	0.55	0.9	-0.23		0.88	0.66	0.83	0.75	0.48	0.81	0.86	0.7	0.44	-0.83	-0.18	-0.83	0.97	0.98	0.82
Short Term Debt	0.92	0.91	0.96	-0.54	-0.9	0.85	0.77	0.81	-0.2	0.88		0.39	0.94	0.92	0.37	0.78	0.94	0.56	0.72	-0.71	-0.44	-0.71	0.96	0.89	0.94
Intangible Assets	0.62	0.45	0.33	-0.62	-0.34	0.7	-0.06	0.66	0.23	0.66	0.39		0.34	0.27	0.33	0.55	0.36	0.75	-0.03	-0.66	0.21	-0.66	0.53	0.64	0.28
Common Stock	0.89	0.82	0.98	-0.41	-0.97	0.77	0.88	0.84	-0.21	0.83	0.94	0.34		0.96	0.52	0.77	0.98	0.65	0.81	-0.8	-0.58	-0.8	0.91	0.83	0.95
Property Plant Equipment	0.83	0.78	0.95	-0.35	-0.92	0.71	0.91	0.77	-0.14	0.75	0.92	0.27	0.96		0.34	0.68	0.92	0.51	0.82	-0.7	-0.6	-0.7	0.86	0.75	0.93
Current Deferred Revenue	0.51	0.46	0.42	-0.28	-0.62	0.48	0.36	0.66	-0.11	0.48	0.37	0.33	0.52	0.34		0.42	0.62	0.76	0.27	-0.57	-0.19	-0.57	0.46	0.45	0.48
Short Term Investments	0.84	0.65	0.81	-0.32	-0.72	0.7	0.52	0.76	-0.18	0.81	0.78	0.55	0.77	0.68	0.42		0.71	0.65	0.7	-0.84	-0.26	-0.84	0.77	0.73	0.72
Capital Surpluse	0.9	0.87	0.95	-0.51	-0.98	0.83	0.84	0.87	-0.21	0.86	0.94	0.36	0.98	0.92	0.62	0.71		0.68	0.71	-0.76	-0.51	-0.76	0.93	0.86	0.95
Deferred Long Term Liab	0.72	0.55	0.59	-0.45	-0.68	0.69	0.39	0.82	0.17	0.7	0.56	0.75	0.65	0.51	0.76	0.65	0.68		0.35	-0.8	-0.22	-0.8	0.65	0.69	0.56
Long Term Investments	0.55	0.5	0.81	0.15	-0.75	0.32	0.86	0.47	-0.18	0.44	0.72	-0.03	0.81	0.82	0.27	0.7	0.71	0.35		-0.58	-0.71	-0.58	0.56	0.4	0.75
Long Term Debt	-0.84	-0.66	-0.8	0.47	0.77	-0.72	-0.54	-0.78	0.28	-0.83	-0.71	-0.66	-0.8	-0.7	-0.57	-0.84	-0.76	-0.8	-0.58		0.29	1.0	-0.77	-0.77	-0.69
Good Will	-0.22	-0.19	-0.56	-0.17	0.45	-0.16	-0.75	-0.23	0.08	-0.18	-0.44	0.21	-0.58	-0.6	-0.19	-0.26	-0.51	-0.22	-0.71	0.29		0.29	-0.31	-0.25	-0.41
Long Term Debt Total	-0.84	-0.66	-0.8	0.47	0.77	-0.72	-0.54	-0.78	0.28	-0.83	-0.71	-0.66	-0.8	-0.7	-0.57	-0.84	-0.76	-0.8	-0.58	1.0	0.29		-0.77	-0.77	-0.69
Net Invested Capital	0.98	0.92	0.92	-0.71	-0.89	0.93	0.68	0.89	-0.22	0.97	0.96	0.53	0.91	0.86	0.46	0.77	0.93	0.65	0.56	-0.77	-0.31	-0.77		0.97	0.91
Net Working Capital	0.95	0.86	0.85	-0.82	-0.79	0.97	0.54	0.87	-0.22	0.98	0.89	0.64	0.83	0.75	0.45	0.73	0.86	0.69	0.4	-0.77	-0.25	-0.77	0.97		0.79
Capital Stock	0.89	0.88	0.93	-0.43	-0.96	0.75	0.85	0.82	-0.2	0.82	0.94	0.28	0.95	0.93	0.48	0.72	0.95	0.56	0.75	-0.69	-0.41	-0.69	0.91	0.79

Click cells to compare fundamentals

About Zymeworks Common Financial Statements

Zymeworks Common stakeholders use historical fundamental indicators, such as Zymeworks Common's Interest Income, to determine how well the company is positioned to perform in the future. Although Zymeworks Common investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zymeworks Common's assets and liabilities are reflected in the revenues and expenses on Zymeworks Common's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zymeworks Common Stock. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Interest Income	22.9 M	24.1 M
Net Interest Income	22.9 M	24.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

FSLY	Fastly Class A
MOB	Mobilicom Limited American
CMG	Chipotle Mexican Grill

When determining whether Zymeworks Common Stock is a strong investment it is important to analyze Zymeworks Common's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zymeworks Common's future performance. For an informed investment choice regarding Zymeworks Stock, refer to the following important reports:

How To Invest In Zymeworks

Details

Is Zymeworks Stock a good investment?

Details

What is Zymeworks Common's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Zymeworks Common Correlation against competitors.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Will Biotechnology sector continue expanding? Could Zymeworks diversify its offerings? Factors like these will boost the valuation of Zymeworks Common. Anticipated expansion of Zymeworks directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Zymeworks Common data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Earnings Share

(0.85)

Revenue Per Share

1.788

Quarterly Revenue Growth

0.726

Return On Assets

(0.1)

Return On Equity

(0.18)

Zymeworks Common Stock's market price often diverges from its book value, the accounting figure shown on Zymeworks's balance sheet. Smart investors calculate Zymeworks Common's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Zymeworks Common's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.

Please note, there is a significant difference between Zymeworks Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zymeworks Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zymeworks Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Zymeworks Interest Income from 2010 to 2026

Latest Zymeworks Common's Interest Income Growth Pattern

Zymeworks Interest Income Regression Statistics

Zymeworks Interest Income History

Other Fundumenentals of Zymeworks Common Stock

Zymeworks Common Interest Income component correlations

About Zymeworks Common Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY